Tecogen (TGEN) CEO Abinand Rangesh Buys 174,081 Shares

On June 26, 2026, Abinand Rangesh, the Chief Executive Officer of TGEN, bought 174,081 shares of the company. This insider purchase adds to a series of transactions that day, reflecting active engagement from TGEN's leadership.

Other Institutional Activity in TGEN

Several institutional investors made changes to their TGEN holdings. Vanguard Capital Management LLC opened a new position with 769,964 shares valued at approximately $1.97 million. Meanwhile, Bard Associates Inc reduced its stake by 798 shares, holding 688,309 shares worth about $1.76 million. Clear Harbor Asset Management, LLC increased its holdings by 40,000 shares to a total of 650,000 shares, valued at $1.66 million. Portolan Capital Management, LLC trimmed its position slightly by 2,255 shares, ending with 443,555 shares valued at $1.14 million.

Tecogen Inc. Stock Up 67.3%

Shares of TGEN traded at around $5.22 on Wednesday. With a broad range of institutional interest, the stock remains an active choice among investors. While specific financial metrics such as market cap and P/E ratio were not available, the stock's trading activity suggests ongoing interest.

Insider Buying and Selling at Tecogen Inc.

In addition to Rangesh's purchase, other insiders were active on June 26, 2026. Angelina Galiteva bought 25,000 shares at an average price of $5.17. Roger Deschenes, the Chief Accounting Officer, purchased 29,013 shares, while Stephen Lafaille, VP of Business Development, also acquired 29,013 shares. Robert Panora, COO and President, added 9,671 shares to his holdings. These transactions were not part of any prearranged plans, demonstrating direct insider confidence.

Analysts Set New Price Targets

Roth Capital initiated coverage on TGEN with a buy rating and a price target of $15.0 on August 18, 2025. H.C. Wainwright reiterated its buy rating with a target of $4.5 back on March 17, 2023. These ratings underscore analysts' positive outlook on TGEN.

Bottom Line

The recent insider buying by TGEN's CEO and other executives signals confidence in the company's prospects. Institutional investors are also adjusting their positions, indicating varied interest levels. Analyst ratings from Roth Capital and H.C. Wainwright further highlight the stock's potential. As always, keep in mind that 13F filings and insider transactions are backward-looking and may not reflect the current state of holdings.